Recent Patents on Inflammation & Allergy Drug Discovery
Title:Patent Selections
Volume: 7 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections, Recent Patents on Inflammation & Allergy Drug Discovery 2013; 7 (3) . https://dx.doi.org/10.2174/1872213X11307030010
DOI https://dx.doi.org/10.2174/1872213X11307030010 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
10
Related Articles
-
Evaluation of the <i>In Vivo</i> Acute Toxicity and <i>In Vitro</i> Hemolytic and Immunomodulatory Activities of the <i>Moringa oleifera</i> Flower Trypsin Inhibitor (MoFTI)
Protein & Peptide Letters Artificial Hibernation by Phenothiazines: A Potential Neuroprotective Therapy Against Cerebral Inflammation in Stroke
Current Neurovascular Research Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production
Current Drug Targets - Inflammation & Allergy HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
Infectious Disorders - Drug Targets Is Preoperative Endoscopic Biliary Drainage Indicated for Jaundiced Patients with Resectable Pancreatic Cancer?
Current Drug Targets Niacin Status, NAD Distribution and ADP-Ribose Metabolism
Current Pharmaceutical Design Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
Current Medicinal Chemistry The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies
Current Molecular Medicine Meet the Editorial Board Member
Current Drug Targets Adrenomedullin: Exciting New Horizons
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Polyamines in Gut Inflammation and Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells
Current Drug Targets - Immune, Endocrine & Metabolic Disorders New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry ‘Do not Do’ Recommendations in Hemophilia
Cardiovascular & Hematological Disorders-Drug Targets Natural Fused Heterocyclic Flavonoids: Potent Candidates as Anti- Inflammatory and Anti-Allergic Agents in the Treatment of Asthma
Current Bioactive Compounds “Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development
Current Medicinal Chemistry Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design Pharmacoinformatic Approaches to Design Natural Product Type Ligands of ABC-Transporters
Current Pharmaceutical Design Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections
Current Pharmaceutical Design